Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1143
TNBC
Basal A
Docetaxel
TUBB
TUBB
9233.002
uM
0.01724
0.01845
-0.1472 -0.2018 4.9997 0.5924
0.9660
0.9358
HCC1143
TNBC
Basal A
Docetaxel
TUBB
TUBB
7810.002
uM
0.00412
0.00608
-0.2888 -0.2655 1.0948 0.7382
0.9669
1.1625
HCC1143
TNBC
Basal A
Doxorubicin
TOP2
TOP
9233.121
uM
0.23336
0.58881
-0.9209 -0.8258 1.0537 0.7010
0.9918
0.9468
HCC1143
TNBC
Basal A
Doxorubicin
TOP2
TOP
7810.007
uM
0.47212
0.57511
-0.9538 -0.8410 5.0000 0.7108
0.9954
0.9616
HCC1143
TNBC
Basal A
Epirubicin
TOP2
TOP
7809.017
uM
0.16457
0.65415
-0.9582 -0.8345 0.7114 0.7917
0.9710
1.7591
HCC1143
TNBC
Basal A
Epirubicin
TOP2
TOP
7810.017
uM
0.36613
0.54129
-0.9998 -0.8995 2.6326 0.8182
0.9965
0.8986
HCC1143
TNBC
Basal A
Erlotinib
EGFR
ErbB
7430.091
uM
91.99970
35.51210
0.5411 0.2413 0.6921 0.0640
0.9318
1.7667
HCC1143
TNBC
Basal A
Etoposide
TOP2
TOP
7430.074
uM
6.14930
15.20170
-0.4426 -0.5494 0.8191 0.3723
0.9968
1.6943
HCC1143
TNBC
Basal A
Everolimus
MTOR
MTOR
12112.164
uM
3.27530
20.7090
-0.6745 -1.0000 0.5957 0.3644
0.7628
1.9275
HCC1143
TNBC
Basal A
Fascaplysin
CDK4
CDK
7430.085
uM
0.31162
0.48073
-0.8868 -0.8580 2.3047 0.6072
0.9972
1.9592
HCC1143
TNBC
Basal A
FR180204
ERK1/2
MAPK
12112.161
uM
95.97580
456.18670
0.4862 -1.0000 0.7048 0.1069
0.7799
1.7182
HCC1143
TNBC
Basal A
FTase Inhibitor I
Ftase
MAPK
12112.154
uM
inf
inf
0.8713 0.8713 0.0000 0.0797
-0.0472
1.8321
HCC1143
TNBC
Basal A
Gefitinib
EGFR
ErbB
9233.049
uM
inf
8.98950
0.7384 0.6348 0.6252 0.0395
0.8403
1.0911
HCC1143
TNBC
Basal A
Gefitinib
EGFR
ErbB
7809.016
uM
11.17440
51.71960
0.1136 -1.0000 0.7170 0.1689
0.8712
1.6622
HCC1143
TNBC
Basal A
Gefitinib
EGFR
ErbB
7810.016
uM
7.79570
9.10660
0.0537 -0.1148 1.3297 0.1171
0.9833
0.9032
HCC1143
TNBC
Basal A
Geldanamycin
HSP90
HSP90
9233.049
uM
0.11132
0.12087
-0.1985 -0.2545 5.0000 0.6576
0.9923
1.0911
HCC1143
TNBC
Basal A
Geldanamycin
HSP90
HSP90
7810.012
uM
0.05388
0.06177
-0.2822 -0.2227 2.6971 0.6873
0.9964
0.9298
HCC1143
TNBC
Basal A
Gemcitabine
DNA replication
DNA replication
9233.12
uM
0.01453
0.01483
-0.1546 -0.0524 5.0000 0.6951
0.9750
1.1442
HCC1143
TNBC
Basal A
Gemcitabine
DNA replication
DNA replication
7810.011
uM
0.00704
0.00710
-0.1045 -0.0221 4.9999 0.7914
0.9757
0.9243
HCC1143
TNBC
Basal A
Glycyl-H-1152
ROCK2
12112.16
uM
13.0250
4.55930
0.3445 0.2984 0.8653 0.1600
0.9739
1.7073
HCC1143
TNBC
Basal A
GM6001
MMP
MMP
7430.096
uM
inf
999.99930
0.8237 0.5783 0.1530 0.0823
0.6514
2.0162
HCC1143
TNBC
Basal A
GSK1070916
AURK
AURK
9233.001
uM
3.20110
8.78260
-0.8187 -1.0000 1.0885 0.3233
0.9120
0.9839
HCC1143
TNBC
Basal A
GSK1070916
AURK
AURK
7810.001
uM
1.93580
6.36580
-0.8483 -1.0000 0.9229 0.3410
0.9271
0.9063
HCC1143
TNBC
Basal A
GSK1838705A
IGF1R
RTK
7430.098
uM
3.22180
2.84250
0.0714 0.2328 5.0000 0.1954
0.9402
1.9267
HCC1143
TNBC
Basal A
GSK1838705A
IGF1R
RTK
7430.091
uM
3.05210
6.80580
-0.8432 -0.9663 1.3416 0.4548
0.9821
1.7667